335 related articles for article (PubMed ID: 16299790)
61. Chemoradiotherapy in adenocarcinoma of the stomach or esophagus.
Hottenrott C; Ziogas D
Ann Surg Oncol; 2010 Jun; 17(6):1715-6; author reply 1717. PubMed ID: 20339949
[No Abstract] [Full Text] [Related]
62. Radiotherapy in the adjuvant management of pancreatic adenocarcinoma.
Abrams RA
Semin Oncol; 2005 Dec; 32(6 Suppl 9):S30-2. PubMed ID: 16399427
[TBL] [Abstract][Full Text] [Related]
63. Molecular biological challenges in he treatment of esophageal adenocarcinoma.
Boonstra JJ; Dinjens WN; Tilanus HW; Koppert LB
Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):275-86. PubMed ID: 19072420
[TBL] [Abstract][Full Text] [Related]
64. Preoperative therapy for esophageal cancer.
Ku GY; Ilson DH
Gastroenterol Clin North Am; 2009 Mar; 38(1):135-52, ix. PubMed ID: 19327572
[TBL] [Abstract][Full Text] [Related]
65. Feasibility of preoperative combined radiation therapy and chemotherapy with 5-fluorouracil and cisplatin in potentially resectable pancreatic adenocarcinoma: The French SFRO-FFCD 97-04 Phase II trial.
Mornex F; Girard N; Scoazec JY; Bossard N; Ychou M; Smith D; Seitz JF; Valette PJ; Roy P; Rouanet P; Ducreux M; Partensky C
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1471-8. PubMed ID: 16793214
[TBL] [Abstract][Full Text] [Related]
66. Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.
Barbour AP; Jones M; Gonen M; Gotley DC; Thomas J; Thomson DB; Burmeister B; Smithers BM
Ann Surg Oncol; 2008 Oct; 15(10):2894-902. PubMed ID: 18663531
[TBL] [Abstract][Full Text] [Related]
67. Prospective comparison of surgery alone and chemoradiotherapy with selective surgery in resectable squamous cell carcinoma of the esophagus.
Ariga H; Nemoto K; Miyazaki S; Yoshioka T; Ogawa Y; Sakayauchi T; Jingu K; Miyata G; Onodera K; Ichikawa H; Kamei T; Kato S; Ishioka C; Satomi S; Yamada S
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):348-56. PubMed ID: 19735862
[TBL] [Abstract][Full Text] [Related]
68. [Prediction of response to neoadjuvant chemotherapy in Barrett's carcinoma by quantitative gene expression analysis].
Langer R; Specht K; Becker K; Ewald P; Sarbia M; Busch R; Feith M; Stein HJ; Siewert JR; Höfler H
Verh Dtsch Ges Pathol; 2004; 88():207-13. PubMed ID: 16892554
[TBL] [Abstract][Full Text] [Related]
69. Adjuvant therapy following resection for pancreatic adenocarcinoma.
Brennan MF
Surg Oncol Clin N Am; 2004 Oct; 13(4):555-66, vii. PubMed ID: 15350934
[TBL] [Abstract][Full Text] [Related]
70. Adjuvant radiotherapy and radiochemotherapy in the management of esophageal cancer: a review of the literature.
Carcaterrra M; Osti MF; De Sanctis V; Caruso C; Berardi F; Enrici RM
Rays; 2005; 30(4):319-22. PubMed ID: 16792007
[TBL] [Abstract][Full Text] [Related]
71. Salvage surgery after failed chemoradiotherapy in squamous cell carcinoma of the esophagus.
Chao YK; Chan SC; Chang HK; Liu YH; Wu YC; Hsieh MJ; Tseng CK; Liu HP
Eur J Surg Oncol; 2009 Mar; 35(3):289-94. PubMed ID: 18396384
[TBL] [Abstract][Full Text] [Related]
72. Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial.
Morak MJ; van der Gaast A; Incrocci L; van Dekken H; Hermans JJ; Jeekel J; Hop WC; Kazemier G; van Eijck CH
Ann Surg; 2008 Dec; 248(6):1031-41. PubMed ID: 19092348
[TBL] [Abstract][Full Text] [Related]
73. Recent changes and the future roles of esophageal cancer surgery.
Nishimaki T; Shimoji H; Sunagawa H
Ann Thorac Cardiovasc Surg; 2004 Dec; 10(6):324-32. PubMed ID: 15658903
[TBL] [Abstract][Full Text] [Related]
74. Adjuvant treatment for resectable pancreatic cancer.
Chua YJ; Cunningham D
J Clin Oncol; 2005 Jul; 23(20):4532-7. PubMed ID: 16002844
[TBL] [Abstract][Full Text] [Related]
75. New developments in the treatment of esophageal cancer.
Ilson DH
Clin Adv Hematol Oncol; 2004 Feb; 2(2):97-104. PubMed ID: 16163169
[TBL] [Abstract][Full Text] [Related]
76. [Clinical practice guidelines: 2004 Standards, Options and Recommendations for the management of patient with adenocarcinoma of the stomach--radiotherapy].
Ychou M; Gory-Delabaere G; Blanc P; Bosquet L; Duffour J; Giovannini M; Guillemin F; Lemanski C; Marchal F; Masson B; Merrouche Y; Monges G; Adenis A; Bosset JF; Bouché O; Conroy T; Pezet D; Triboulet JP; ; ;
Cancer Radiother; 2004 Oct; 8(5):322-35. PubMed ID: 15561598
[TBL] [Abstract][Full Text] [Related]
77. Preoperative chemoradiation therapy for adenocarcinoma of the pancreas: The Fox Chase Cancer Center experience, 1986-2003.
Meszoely IM; Wang H; Hoffman JP
Surg Oncol Clin N Am; 2004 Oct; 13(4):685-96, x. PubMed ID: 15350942
[TBL] [Abstract][Full Text] [Related]
78. Evolving role of chemoradiation in the adjuvant treatment of gastric cancer.
Leong T
Expert Rev Anticancer Ther; 2004 Aug; 4(4):585-94. PubMed ID: 15270662
[TBL] [Abstract][Full Text] [Related]
79. Use of oesophagogastroscopy to assess the response of oesophageal carcinoma to neoadjuvant therapy.
Brown WA; Thomas J; Gotley D; Burmeister BH; Lim KH; Martin I; Walpole ET; Thomson DB; Harvey JA; Smithers BM
Br J Surg; 2004 Feb; 91(2):199-204. PubMed ID: 14760668
[TBL] [Abstract][Full Text] [Related]
80. [Surgery of cancer of the esophagus].
Triboulet JP
Rev Prat; 1999 Jun; 49(11):1180-5. PubMed ID: 10416349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
